AAAAAA

   
Results: 1-21 |
Results: 21
Immunoglobulin variable region structure and B-cell malignancies
Authors: Kiyoi, H Naoe, T
Citation: H. Kiyoi et T. Naoe, Immunoglobulin variable region structure and B-cell malignancies, INT J HEMAT, 73(1), 2001, pp. 47-53
Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations
Authors: Hanamura, I Iida, S Akano, Y Hayami, Y Kato, M Miura, K Harada, S Banno, S Wakita, A Kiyoi, H Naoe, T Shimizu, S Sonta, S Nitta, M Taniwaki, M Ueda, R
Citation: I. Hanamura et al., Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations, JPN J CANC, 92(6), 2001, pp. 638-644
FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy
Authors: Naoe, T Kiyoi, H Yamamoto, Y Minami, Y Yamamoto, K Ueda, R Saito, H
Citation: T. Naoe et al., FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy, CANC CHEMOT, 48, 2001, pp. S27-S30
B-cell precursors differentiated from cord blood CD34(+) cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34(+) cells
Authors: Hirose, Y Kiyoi, H Itoh, K Kato, K Saito, H Naoe, T
Citation: Y. Hirose et al., B-cell precursors differentiated from cord blood CD34(+) cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34(+) cells, IMMUNOLOGY, 104(4), 2001, pp. 410-417
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Authors: Yamamoto, Y Kiyoi, H Nakano, Y Suzuki, R Kodera, Y Miyawaki, S Asou, N Kuriyama, K Yagasaki, F Shimazaki, C Akiyama, H Saito, K Nishimura, M Motoji, T Shinagawa, K Takeshita, A Saito, H Ueda, R Ohno, R Naoe, T
Citation: Y. Yamamoto et al., Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies, BLOOD, 97(8), 2001, pp. 2434-2439
Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia
Authors: Naoe, T Takeyama, K Yokozawa, T Kiyoi, H Seto, M Uike, N Ino, T Utsunomiya, A Maruta, A Jin-Nai, I Kamada, N Kubota, Y Nakamura, H Shimazaki, C Horiike, S Kodera, Y Saito, H Ueda, R Wiemels, J Ohno, R
Citation: T. Naoe et al., Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia, CLIN CANC R, 6(10), 2000, pp. 4091-4095
Leukemia relapse reconsidered from the molecular aspect
Authors: Naoe, T Nakano, Y Kiyoi, H
Citation: T. Naoe et al., Leukemia relapse reconsidered from the molecular aspect, LEUK LYMPH, 37(5-6), 2000, pp. 527-534
Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
Authors: Hayakawa, F Towatari, M Kiyoi, H Tanimoto, M Kitamura, T Saito, H Naoe, T
Citation: F. Hayakawa et al., Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines, ONCOGENE, 19(5), 2000, pp. 624-631
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia
Authors: Nakano, Y Naoe, T Kiyoi, H Kitamura, K Minami, S Miyawaki, S Asou, N Kuriyama, K Kusumoto, S Shimazaki, C Akiyama, H Saito, K Nishimura, M Motoji, T Shinagawa, K Saito, H Ohno, R
Citation: Y. Nakano et al., Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia, EUR J HAEMA, 65(1), 2000, pp. 23-31
In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor
Authors: Zhao, M Kiyoi, H Yamamoto, Y Ito, M Towatari, M Omura, S Kitamura, T Ueda, R Saito, H Naoe, T
Citation: M. Zhao et al., In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor, LEUKEMIA, 14(3), 2000, pp. 374-378
Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis
Authors: Kitamura, K Minami, Y Yamamoto, K Akao, Y Kiyoi, H Saito, H Naoe, T
Citation: K. Kitamura et al., Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis, LEUKEMIA, 14(10), 2000, pp. 1743-1750
Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia
Authors: Yokozawa, T Towatari, M Iida, H Takeyama, K Tanimoto, M Kiyoi, H Motoji, T Asou, N Saito, K Takeuchi, M Kobayashi, Y Miyawaki, S Kodera, Y Ohno, R Saito, H Naoe, T
Citation: T. Yokozawa et al., Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia, LEUKEMIA, 14(1), 2000, pp. 28-33
Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia
Authors: Nakano, Y Naoe, T Kiyoi, H Kunishima, S Minami, S Miyawaki, S Asou, N Kuriyama, K Saito, H Ohno, R
Citation: Y. Nakano et al., Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia, LEUK RES, 24(4), 2000, pp. 349-352
Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid
Authors: Kitamura, K Hoshi, S Koike, M Kiyoi, H Saito, H Naoe, T
Citation: K. Kitamura et al., Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid, BR J HAEM, 108(4), 2000, pp. 696-702
Identification of a novel putative Ran-binding protein and its close homologue
Authors: Koch, P Bohlmann, I Schafer, M Hansen-Hagge, TE Kiyoi, H Wilda, M Hameister, H Bartram, CR Janssen, JWG
Citation: P. Koch et al., Identification of a novel putative Ran-binding protein and its close homologue, BIOC BIOP R, 278(1), 2000, pp. 241-249
Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy
Authors: Kosugi, H Towatari, M Hatano, S Kitamura, K Kiyoi, H Kinoshita, T Tanimoto, M Murate, T Kawashima, K Saito, H Naoe, T
Citation: H. Kosugi et al., Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy, LEUKEMIA, 13(9), 1999, pp. 1316-1324
Reply - Review of the immunoglobulin light chain variable region sequencesfrom multiple myeloma cells
Authors: Kiyoi, H Naoe, T
Citation: H. Kiyoi et T. Naoe, Reply - Review of the immunoglobulin light chain variable region sequencesfrom multiple myeloma cells, LEUKEMIA, 13(5), 1999, pp. 829-830
Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation
Authors: Iida, M Towatari, M Nakao, A Iida, H Kiyoi, H Nakano, Y Tanimoto, M Saito, H Naoe, T
Citation: M. Iida et al., Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation, LEUKEMIA, 13(4), 1999, pp. 585-589
Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation
Authors: Mizuta, S Ito, Y Kohno, A Kiyoi, H Miyamura, K Tanimoto, M Takamatsu, J Naoe, T Morishima, Y Ueda, R Saito, H
Citation: S. Mizuta et al., Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation, BONE MAR TR, 24(7), 1999, pp. 777-784
Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene
Authors: Nakano, Y Kiyoi, H Miyawaki, S Asou, N Ohno, R Saito, H Naoe, T
Citation: Y. Nakano et al., Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene, BR J HAEM, 104(4), 1999, pp. 659-664
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
Authors: Kiyoi, H Naoe, T Nakano, Y Yokota, S Minami, S Miyawaki, S Asou, N Kuriyama, K Jinnai, I Shimazaki, C Akiyama, H Saito, K Oh, H Motoji, T Omoto, E Saito, H Ohno, R Ueda, R
Citation: H. Kiyoi et al., Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia, BLOOD, 93(9), 1999, pp. 3074-3080
Risultati: 1-21 |